Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LSD Therapy

Recent news which mentions LSD Therapy

Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
Tickers DOGS PETS
Tags Benzinga Psychedelics Psychedelics Research
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Tickers MNMD NEWS
Tags Interview Psychedelics Benzinga
From Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
Tickers MNMD NEWS
Tags MNMD Biotech Psychedelics
From Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Tickers CMPS MNMD NEWS
Tags News Breakthrough Therapy Drug LSD Therapy
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Tickers MNMD
Tags Financing Management Psychedelic/Assisted Therapies
From Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
Tickers MNMD NEWS
Tags Psychedelics Benzinga Generalized Anxiety Disorder
From Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
Tags Psychedelic/Assisted Therapies General Entertainment
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags Psychedelic/Assisted Therapies FDA PHRRF
From Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
Tickers CMPS MNMD NUMIF
Tags MNMD Psychedelics Benzinga
From Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
Tickers MNMD
Tags Proxy fight FCM MM Holdings Psychedelic/Assisted Therapies
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
Tickers MNMD
Tags Psychedelic/Assisted Therapies Management MNMD
From Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
Tickers MNMD
Tags Guidance financials News
From Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
Tickers MNMD
Tags LSD Therapy Global major depressive disorder
From Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
Tags News British Journal of Pharmacology Psychedelics
From Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
Tickers AWKNF CMND CMPS PSIL
Tags Psychedelic Research Benzinga Psychedelics
From Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
Tickers MNMD
Tags Robert Barrow MNMD Psychedelics
From Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
Tickers BLRZF
Tags Markets Cannabis Market News
From Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
Tickers BETRF
Tags Markets BETRF Market News
From Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
Tickers MNMD
Tags LSD Therapy Cannabis Biological Psychiatry
From Benzinga
Connecting To Nature Through Psychedelics
Tickers TECH
Tags Tech Nature Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.